CHG-2024-0265

Formulation Change for Tisagenlecleux-B. Facility Change for Tisagenlecleux-B — minor update. Impacts 2 markets and 4 variations.

Change Number
CHG-2024-0265
Type
Formulation Change
Product
Tisagenlecleux-B
Status
In Progress
Owner
James O'Brien
Initiated
2023-07-09
Description

Facility Change for Tisagenlecleux-B — minor update

Impacted Markets (2)
ES — SpainBE — Belgium
Impacted Modules
4.2.1
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved